Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £1.77m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

Contract Expansion

8 Jun 2026 07:00

RNS Number : 2738H
Acuity RM Group PLC
08 June 2026
 

This is a Reach (i.e. non-regulatory) announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance.

 

 

8 June 2026

Acuity RM Group plc

("Acuity", or the "Group")

Contract Expansion

Acuity RM Group plc (AIM: ACRM), the software group specialising in cyber-security, which supplies its award-winning STREAM® software platform for the Governance, Risk and Compliance ("GRC") market, together with associated consultancy services, is pleased to announce a contract expansion with an existing customer, a supplier to the nuclear industry comprising the migration of the customer's on-premises STREAM® Classic deployment to STREAM® Classic SaaS and the addition of Third Party Risk Management ("TPRM") capability.

The customer has signed a new three-year contract with a total value in excess of £100,000. The contract comprises both a professional services component, covering the migration and TPRM deployment, and a recurring subscription component.

The contract increases the recurring revenue contribution from this customer and extends the customer relationship for a further three years.

David Rajakovich, CEO of Acuity, commented:

"We are proud that this customer has chosen to expand its relationship with Acuity by migrating from on-premises STREAM® Classic to STREAM® Classic SaaS, signing a new three-year contract and adding Third Party Risk Management. The decision reflects the value the customer draws from STREAM® and the work the Acuity team has done in supporting them over the course of the existing engagement. The agreement increases the recurring revenue contribution from this customer, and the customer has indicated potential for further expansion of its use of STREAM® over the life of the contract."

 

For further information please contact:

Acuity RM Group plc

https://www.acuityrmgroup.com

David Rajakovich CEO / Duncan Harper Finance Director

AlbR Capital (Joint broker)

Lucy Williams / Duncan Vasey

+44 (0) 20 7469 0936

Clear Capital (Joint broker)

Bob Roberts

+44 (0) 20 3869 6080

 

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform which collects and analyses data to improve business decisions and management is used by clients operating in markets including government, defence, broadcasting, utilities, manufacturing and healthcare.

The Company is focused on delivering long term, sustainable growth in shareholder value from organic growth and complementary acquisitions. Information on all the company's products is available on https://acuityrm.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZGGVVKFGVZM
12
Date   Source Headline
7th Feb 20257:00 amPRNChanges in share options
5th Feb 20258:59 amPRNCorrection to Year end Update
4th Feb 20257:00 amPRNTrading Statement
20th Jan 20257:00 amPRNHolding(s) in Company
13th Dec 202412:38 pmPRNBoard Changes
26th Nov 20247:00 amPRNContract
19th Nov 20247:00 amPRNAcquisition
4th Nov 20247:00 amPRNDirectorate Change
7th Oct 20247:00 amPRNHolding(s) in Company
18th Sep 20247:00 amPRNInvestor Presentation via Investor Meet Company
16th Sep 20247:00 amPRNHalf-year Report
5th Aug 20242:34 pmPRNDirector/PDMR Shareholding
15th Jul 20247:05 amPRNChange of Adviser
10th Jul 20242:17 pmPRNNotice of AGM Result
10th Jul 20247:00 amPRNAGM Statement
26th Jun 20244:27 pmRNSGrant of Options
17th Jun 20243:15 pmRNSCorrection: Result of Placing and Subscription
17th Jun 20249:36 amRNSResult of Placing and Subscription
17th Jun 20247:00 amRNSProposed Placing and Subscription
14th Jun 20247:07 amPRNDirectorate Change
14th Jun 20247:00 amPRNAnnual Financial Report
13th Jun 20247:34 amPRNAnnual Financial Report
10th Jun 20247:00 amRNSNew professional services agreement and order
13th May 20247:00 amPRNContract
8th May 20247:00 amRNSNew partnership and order
22nd Apr 20247:00 amRNSNew product launch
11th Mar 202410:33 amPRNHolding(s) in Company
25th Jan 20247:00 amPRNContract win
17th Jan 20247:00 amPRNYear end Update
18th Dec 20237:00 amRNSNew Contract win
12th Dec 20237:00 amPRNContract and Corporate Update
10th Nov 20237:00 amPRNHolding(s) in Company
31st Oct 20237:00 amRNSNew Contract win
10th Oct 20237:00 amRNSNew Contract win
9th Oct 20233:56 pmPRNIssue of Equity
6th Oct 20237:00 amPRNDirectorate Change
28th Sep 20238:04 amPRNHalf-year Report
28th Sep 20237:57 amPRNFinal Results
5th Sep 20237:00 amRNSNew Contract win
20th Jul 20237:00 amPRNContract win
4th Jul 20237:00 amPRNDirectorate Changes
27th Jun 202311:15 amPRNResult of AGM
23rd Jun 20237:00 amPRNDirectorate Change
9th Jun 20237:00 amRNSContract win
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.